Evidence map›Paper›PMID 22891032›Full record

ArticleMolecular biology and evolution2012

Population genomics of Chlamydia trachomatis: insights on drift, selection, recombination, and population structure.

Sandeep J Joseph, Xavier Didelot, James Rothschild, Henry J C de Vries, Servaas A Morré, Timothy D Read, Deborah Dean

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology and evolution, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Putative azithromycin resistance mutations inAntimicrobial agents and chemotherapy · 2026
    Article
  3. Laboratory detection methods for Chlamydia trachomatis infection in children: a review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Microorganisms · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Patterns of within-host spread ofbioRxiv : the preprint server for biology · 2023
    Article
  11. Genome organization and genomics inFrontiers in cellular and infection microbiology · 2023
    Review
  12. Patterns of within-host spread ofFrontiers in microbiology · 2023
    Article
  13. Review
  14. The Impact of Lateral Gene Transfer inFrontiers in cellular and infection microbiology · 2022
    Review
  15. Vaccines · 2021
    Article
  16. Article
  17. Ongoing evolution ofMicrobial genomics · 2021
    Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Sandeep J JosephDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, USA.
Xavier Didelot
James Rothschild
Henry J C de Vries
Servaas A Morré
Timothy D Read
Deborah Dean
Emory University · USAmsterdam UMC Location VUmc · NLGGD Amsterdam · NLImperial College London · GBUniversity of California, San Francisco · US

Funding

Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogensR01AI098843 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DEAN, DEBORAH ANNE, READ, TIMOTHY D. · 2012 to 2016
$5.5M
C. trachomatis genomics, strain typing, and evolutionR01AI059647 · NIAID · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI DEAN, DEBORAH ANNE · 2004 to 2008
$2.8M
Medical Research Council G0600719NIAID NIH HHS R01 AI059647NIAID NIH HHS R01AI059647NIAID NIH HHS R01 AI098843
6 · The paper itself

Abstract

The large number of sexually transmitted diseases and ocular trachoma cases that are caused globally each year by Chlamydia trachomatis has made this organism a World Health Organization priority for vaccine development. However, there is no gene transfer system for Chlamydia to help identify potential vaccine targets. To accelerate discoveries toward this goal, here we analyzed the broadest diversity of C. trachomatis genomes to date, including 25 geographically dispersed clinical and seven reference strains representing 14 of the 19 known serotypes. Strikingly, all 32 genomes were found to have evidence of DNA acquisition by homologous recombination in their history. Four distinct clades were identified, which correspond to all C. trachomatis disease phenotypes: lymphogranuloma venereum (LGV; Clade 1); noninvasive urogenital infections (Clade 2); ocular trachoma (Clade 3); and protocolitis (Clade 4; also includes some noninvasive urogenital infections). Although the ancestral relationship between clades varied, most strains acted as donor and recipient of recombination with no evidence for barriers to genetic exchange. The niche-specific LGV and trachoma clades have undergone less recombination, although the opportunity for mixing with strains from other clades that infect the rectal and ocular mucosa, respectively, is evident. Furthermore, there are numerous occasions for gene conversion events through sequential infections at the same anatomic sites. The size of recombinant segments is relatively small (~357 bp) compared with in vitro experiments of various C. trachomatis strains but is consistent with in vitro estimates for other bacterial species including Escherichia coli and Helicobacter pylori. Selection has also played a crucial role during the diversification of the organism. Clade 2 had the lowest nonsynonymous to synonymous ratio (dN/dS) but the highest effect of recombination, which is consistent with the widespread occurrence of synonymous substitutions in recombined genomic segments. The trachoma Clade 3 had the highest dN/dS estimates, which may be caused by an increased effect of genetic drift from niche specialization and a reduced effective population size. The degree of drift, selection, and recombination in C. trachomatis suggests that the challenge will remain to identify genomic regions that are stable and cross protective for the development of an efficacious vaccine.

Indexed as

Genetic DriftSelection, GeneticBacterial VaccinesBase SequenceBayes TheoremChlamydia trachomatisCluster AnalysisComputational BiologyGenome, BacterialMetagenomicsModels, GeneticMolecular Sequence DataPhylogenyRecombination, GeneticSequence AlignmentSequence Analysis, DNABacterial Vaccines

Identifiers

PMID22891032
PMCPMC3494276
OpenAlexW2125304134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.